BEGHE', Bianca
 Distribuzione geografica
Continente #
NA - Nord America 12.295
EU - Europa 5.449
AS - Asia 2.259
SA - Sud America 143
AF - Africa 35
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.219
Nazione #
US - Stati Uniti d'America 12.249
GB - Regno Unito 1.926
IT - Italia 1.375
SG - Singapore 799
CN - Cina 644
SE - Svezia 500
DE - Germania 405
UA - Ucraina 315
HK - Hong Kong 269
RU - Federazione Russa 189
TR - Turchia 187
FI - Finlandia 185
ID - Indonesia 157
FR - Francia 152
BG - Bulgaria 144
BR - Brasile 82
IE - Irlanda 35
NL - Olanda 33
AU - Australia 29
IN - India 29
CO - Colombia 28
CA - Canada 27
RO - Romania 27
LT - Lituania 26
ES - Italia 25
IR - Iran 25
KR - Corea 25
BE - Belgio 24
PK - Pakistan 24
MY - Malesia 21
VN - Vietnam 21
CH - Svizzera 20
MX - Messico 16
ZA - Sudafrica 14
CL - Cile 13
AR - Argentina 10
PL - Polonia 10
IQ - Iraq 9
BF - Burkina Faso 8
CZ - Repubblica Ceca 8
SY - Repubblica araba siriana 8
AT - Austria 7
JP - Giappone 7
NO - Norvegia 7
SA - Arabia Saudita 6
TW - Taiwan 6
AL - Albania 5
PE - Perù 5
PT - Portogallo 5
EC - Ecuador 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
BD - Bangladesh 3
EE - Estonia 3
EG - Egitto 3
EU - Europa 3
LV - Lettonia 3
LY - Libia 3
NI - Nicaragua 3
SI - Slovenia 3
TH - Thailandia 3
AO - Angola 2
DK - Danimarca 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
PH - Filippine 1
TN - Tunisia 1
TZ - Tanzania 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 20.219
Città #
Fairfield 1.598
Southend 1.573
Santa Clara 1.351
Woodbridge 979
Chandler 931
Ashburn 856
Houston 820
Jacksonville 661
Seattle 561
Wilmington 529
Cambridge 511
Dearborn 504
Singapore 467
Ann Arbor 360
Hong Kong 263
Nyköping 240
Modena 221
Beijing 201
San Diego 187
New York 167
Princeton 161
Sofia 144
Eugene 116
Milan 95
Rome 92
Izmir 91
Jakarta 88
London 87
Helsinki 80
Redwood City 75
Des Moines 70
Dallas 62
Moscow 55
Naples 54
Shanghai 41
Falls Church 35
Boardman 34
Dublin 29
Grafing 29
Frankfurt am Main 28
Hefei 27
Bogotá 24
Norwalk 24
Verona 23
Bologna 19
Brussels 19
Nanjing 19
Florence 18
Saint Petersburg 18
Los Angeles 17
Timisoara 17
Bari 15
Chiswick 15
Kilburn 15
Hanoi 14
Palermo 14
Genoa 13
Kunming 13
San Giuliano 13
Toronto 13
Ankara 12
Belluno 12
Hounslow 12
Turin 12
Jinan 11
São Paulo 11
Indiana 10
Munich 10
Bremen 9
Chicago 9
Guangzhou 9
Leeds 9
Medan 9
Parma 9
Phoenix 9
Pontecagnano 9
Prescot 9
Reggio Emilia 9
San Mateo 9
Novara 8
Chengdu 7
Fuzhou 7
Mumbai 7
Napoli 7
Shaoxing 7
Shenyang 7
Amsterdam 6
Ardabil 6
Auburn Hills 6
Augusta 6
Cape Town 6
Carpi 6
Cascina 6
Columbus 6
Dong Ket 6
Monza 6
Nanchang 6
Ouagadougou 6
Padova 6
Philadelphia 6
Totale 15.119
Nome #
The genetic basis of atopic asthma. 531
Asma bronchiale 509
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 371
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 370
Chronic respiratory abnormalities in the multi-morbid frail elderly 297
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 253
La broncopneumopatia cronica ostruttiva nell'anziano 252
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. 246
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 224
We Have to Learn to Do Without Knowing Enough: Anti-Eosinophilic Treatments for Severe Asthma 220
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. 219
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 216
Eosinophilia in asthma: the easy way is not always the best 210
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 210
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 209
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. 206
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 204
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 202
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 201
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 195
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 194
Roflumilast:un nuovo farmaco per il trattamento della BPCO 193
Inhaled Corticosteroids in COPD: Pros and Cons. 192
Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. 191
Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: a risk chart in COPD patients. 180
What is the origin of dyspnoea in smokers without airway disease ? 177
[Pathology of chronic obstructive pulmonary disease] 177
Leukotriene B4 receptor locus gene characterisation and association studies in asthma 176
La genetica dell’asma bronchiale. 176
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 175
Complex chronic co-morbidities of COPD 175
Chronic Obstructive Pulmonary Disease is just one component of the complex multimorbidities in patients with COPD. 172
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 171
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 170
Identifying and Treating COPD in Cardiac Patients 169
Physiologic consequences of long term inflammation 168
Comparison of two methods of processing induced sputum: selected versus entire sputum. 168
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 168
La NIV nel paziente con insufficienza respiratoria cronica, la gestione domiciliare - Competenza specialistica nelle patologie pneumologiche pure 166
Triple therapy for symptomatic patients with COPD 165
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 165
Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice 165
Alveolar and bronchiolar inflammation in COPD 164
Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation. 164
Reply: look at the moon, not just at the finger indicating the moon 164
The multiple components of COPD 163
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. 161
Treatment of chronic obstructive pulmonary disease and its comorbidities 156
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 156
Significant chronic airway abnormalities in never-smoking HIV-infected patients 156
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. 155
Update in Chronic Obstructive Pulmonary Disease 2005 152
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet. 151
Airway inflammation in childhood asthma 149
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) 149
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation 148
Basi strutturali della BPCO. 147
Genetic influences on Asthma Severity. 145
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases 145
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. 144
Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer. 141
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate 141
Cardiac Diseases and respiratory consequences 141
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 140
Update in chronic obstructive pulmonary disease 2006 140
Update in Asthma 2016 140
Comparison of three methods for single nucleotide polymorphism typing for DNA bank studies: sequence-specific oligonucleotide probe hybridisation, TaqMan liquid phase hybridisation, and microplate array diagonal gel electrophoresis (MADGE). 138
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 137
COPD in the elderly is almost invariably associated with one or more chronic comorbidities 137
Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. 136
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 134
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. 134
La broncopneumopatia cronica ostruttiva 132
Role for CXCR6 and its Ligand CXCL16 in the Pathogenesis of T-cell Alveolitis in Sarcoidosis 130
Pathology of COPD and asthma 129
Symptomatic elderly patients. The urgent need for comprehensive assessment and management 129
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema 128
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 128
Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families. 127
The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma 126
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 125
Pneumologia 125
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. 124
Trattamento farmacologico dell’asma bronchiale 123
Pro-Calcitonin guided antibiotic treatment of acute exacerbations of Chrnic Obstructive Pulmonary Disease 122
Neutrophilic infiltration within the airway smooth muscle in patients with COPD 121
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 121
Subclinical cardiac dysfunction in moderate to severe COPD patients 120
Prognostication by concomitant organ failure in mechanically ventilated patients in ICU: important issue to face with 120
Malattie respiratorie ostruttive. Bronchiectasie 119
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 117
Asthma 117
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 115
Blood eosinophils for the management of COPD patients? 114
Trattamento farmacologico dell’asma bronchiale. 113
Acute severe asthma: management and treatment. 109
Decreased expression of TGF-beta type II receptor in bronchial glands of smokers with COPD 106
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials 106
CHRONIC OBSTRUCTIVE PULMOARY DISEASE INTERNATIONAL GUIDELINES 105
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 105
Totale 16.982
Categoria #
all - tutte 104.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.353 0 0 0 0 0 559 646 351 345 116 205 131
2020/20212.908 262 90 258 188 464 247 247 374 114 291 231 142
2021/20222.914 100 297 234 234 95 132 169 157 341 262 562 331
2022/20232.487 256 256 133 224 288 357 83 276 345 64 107 98
2023/20242.004 83 140 115 265 356 207 130 215 87 92 117 197
2024/20252.941 227 176 100 410 1.111 917 0 0 0 0 0 0
Totale 20.463